Reinforces position as first commercially approved contract development and manufacturing organization (CDMO) for ADCs in North America
The Lilly Medicine Foundry is set to drive innovation in drug production and make medicines for clinical trials
The company is also looking at an inorganic opportunity over the next two years to have a commercially ready footprint in the US
Collaboration with KNAUER to streamline and improve the scale-up of LNP formulations
Gross profit was Rs. 328.8 crore, up by 27.8% YoY with a gross margin expansion of 418 bps to 55.7%
The Central government’s decision to exempt three more cancer medicines from customs duty is a commendable step towards making cancer drugs more affordable
Aim of the collaboration is to develop mRNA platform technology, scale up and troubleshoot challenges in mRNA process optimization
Himanshu brings with him a wealth of rich experience from commercial, marketing, and general management roles
Sapala has a strong customer base including innovator Pharma, CDMOs & diagnostic companies
Largest investment in active pharmaceutical ingredient manufacturing of synthetic medicines in U.S. history
Subscribe To Our Newsletter & Stay Updated
